Clinical Trials Browser

Observational × Erlotinib Hydrochloride × Clear all

NCT05834348 2025-03-30

DELINOR

5,279 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT03647592 2023-12-27

Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT02154490 2023-06-01

Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer

1,864 enrolled 12 charts

Recurrent Squamous Cell Lung Carcinoma

NCT04179890 2023-05-25

UpSwinG

462 enrolled 23 charts

Carcinoma, Non-Small-Cell Lung

NCT04575415 2020-10-20

BELLA

NSCLC

NCT04115410 2020-05-28

PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study

Carcinoma, Non-Small-Cell Lung

NCT01782690 2018-07-23

An Observational Study of Erlotinib Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

338 enrolled 18 charts

Gastrointestinal

Pancreatic Neoplasms

NCT01836133 2017-05-04

ELEMENT

70 enrolled 8 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01161173 2016-03-28

TEAM

347 enrolled 10 charts

Nonsquamous Nonsmall Cell Neoplasm of Lung

NCT01664533 2015-12-28

TIME

57 enrolled 10 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT00418704 2013-10-01

Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT00419042 2013-10-01

Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms